Cinnamylpiperazines are an emerging class of synthetic opioids based on the AP-237 scaffold. To prepare for the potential emergence of AP-237 analogs, Cayman's scientists have standardized a naming convention for cinnamylpiperazines that is easy to use and adaptable to future analogs.